ArticleEULAR rheumatology open2026

Early C-reactive protein and ferritin kinetics after tocilizumab initiation predict macrophage activation syndrome in Still disease: a single-centre retrospective cohort study.

Kohei Yo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.